Zydus Lifesciences Ltd 532321
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 1,051.90
- Day Range
- INR 1,104.45–1,104.45
- 52-Week Range
- INR 482.55–1,104.45
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 1.11 Tril
- Volume/Avg
- 33,552 / 49,239
Key Statistics
- Price/Earnings (Normalized)
- 29.98
- Price/Sales
- 5.52
- Dividend Yield (Trailing)
- 0.57%
- Dividend Yield (Forward)
- 0.29%
- Total Yield
- 0.59%
Company Profile
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. The product portfolio of the group includes Active Pharmaceutical Ingredients, human formulations, Health and wellness, and Animal health and veterinary products. Its product brands include Aten, Falcigo, Nucoxia, Levoday, Metscore and Arzep among others. It has two segments Pharmaceuticals and Consumer Products. It generates majority of its revenue from the Pharmaceutical segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 15,343
- Website
- https://www.zyduslife.com
Comparables
Valuation
|
Metric
|
532321
|
TORNTPHARM
|
540222
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.98 | 63.14 | 143.47 |
Price/Book Value | 5.45 | 13.62 | 5.68 |
Price/Sales | 5.52 | 8.85 | 4.64 |
Price/Cash Flow | 27.24 | 39.55 | 44.99 |
Price/Earnings
532321
TORNTPHARM
540222
Financial Strength
|
Metric
|
532321
|
TORNTPHARM
|
540222
|
|---|---|---|---|
Quick Ratio | 1.36 | 0.55 | 0.58 |
Current Ratio | 2.28 | 1.08 | 1.23 |
Interest Coverage | 53.53 | 6.63 | 2.29 |
Quick Ratio
532321
TORNTPHARM
540222
Profitability
|
Metric
|
532321
|
TORNTPHARM
|
540222
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
532321
TORNTPHARM
540222
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Zssctsrwm | Xkcfmw | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Cwbkbyrf | Bcbfj | $79.3 Bil | |
HLN
| Haleon PLC ADR | Vzwwddm | Nyx | $38.1 Bil | |
VTRS
| Viatris Inc | Sdzpzsyp | Wbmh | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wywslskkv | Chqw | $11.7 Bil | |
CTLT
| Catalent Inc | Jsnlzrmxq | Mdmqnp | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Hflrgqqpv | Yxjf | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Skwxlhhsd | Tlyz | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Sxrhcqyy | Lxqgt | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Szbpzycvb | Myj | $3.1 Bil |